Combining measles virus with radiotherapy shows early promise against cancerBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f4512 (Published 12 July 2013) Cite this as: BMJ 2013;347:f4512
- Jacqui Wise
Harnessing the measles virus to target cancer cells as part of a quadruple combination treatment has shown promise in a preclinical study.
Scientists from the Institute of Cancer Research in London say that the “radiovirotherapy” treatment could improve on standard treatments for cancer of the bowel and of the head and neck. Around 50 000 people in the United Kingdom are diagnosed with colorectal carcinoma or head and neck cancer …